Serum hepatitis B viral (HBV) DNA is a predictive biomarker for survival in non-small cell lung cancer patients with chronic HBV infection

Purpose: To study the association between pretreatment serum hepatitis B viral (HBV) DNA copy numbers and clinical outcome of non-small cell lung cancer (NSCLC) patients with chronic HBV infection. Patients and methods: We retrospectively evaluated the medical records of NSCLC HBV (+) patients betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yumei, Yang, Xiaoyi, Liang, Huifen, Wu, Xingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549665/
https://www.ncbi.nlm.nih.gov/pubmed/31213920
http://dx.doi.org/10.2147/CMAR.S198714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549665/
https://www.ncbi.nlm.nih.gov/pubmed/31213920
http://dx.doi.org/10.2147/CMAR.S198714

Ejemplares similares